Prevalence, Awareness, Treatment, and Control of Type 2 Diabetes in South Korea (1998 to 2022): Nationwide Cross-Sectional Study
JMIR Public Health and Surveillance · 2024
DOI: 10.2196/59571 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift JMIR Public Health and Surveillance, 2024. Verfasst von Wonwoo Jang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Kyung Hee University College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, COVID-19, Health Knowledge, Attitudes, Practice. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Type 2 diabetes poses an increasing disease burden in South Korea. The development and management of type 2 diabetes are closely related to lifestyle and socioeconomic factors, which have undergone substantial changes over the past few decades, including during the COVID-19 pandemic.
Objective
This study aimed to investigate long-term trends in type 2 diabetes prevalence, awareness, treatment, and control. It also aimed to determine whether there were substantial alterations in the trends during the pandemic and whether these changes were more pronounced within specific demographic groups.
Methods
This study examined the prevalence, awareness, treatment, and control of type 2 diabetes in a representative sample of 139,786 South Koreans aged >30 years, using data from the National Health and Nutrition Examination Survey and covering the period from 1998 to 2022. Weighted linear regression and binary logistic regression were performed to calculate weighted β coefficients or odds ratios. Stratified analyses were performed based on sex, age, region of residence, obesity status, educational background, household income, and smoking status. β (difference) was calculated to analyze the trend difference between the prepandemic period and the COVID-19 pandemic. To identify groups more susceptible to type 2 diabetes, we estimated interaction terms for each factor and calculated weighted odds ratios.
Results
From 1998 to 2022, a consistent increase in the prevalence of type 2 diabetes was observed among South Koreans, with a notable rise to 15.61% (95% CI 14.83-16.38) during the pandemic. Awareness followed a U-shaped curve, bottoming out at 64.37% (95% CI 61.79-66.96) from 2013 to 2015 before increasing to 72.56% (95% CI 70.39-74.72) during the pandemic. Treatment also increased over time, peaking at 68.33% (95% CI 65.95-70.71) during the pandemic. Control among participants with diabetes showed no substantial change, maintaining a rate of 29.14% (95% CI 26.82-31.47) from 2020 to 2022, while control among treated participants improved to 30.68% (95% CI 27.88-33.48). During the pandemic, there was a steepening of the curves for awareness and treatment. However, while the slope of control among participants being treated increased, the slope of control among participants with diabetes showed no substantial change during the pandemic. Older populations and individuals with lower educational level exhibited less improvement in awareness and control trends than younger populations and more educated individuals. People with lower income experienced a deceleration in prevalence during the pandemic.
Conclusions
Over the recent decade, there has been an increase in type 2 diabetes prevalence, awareness, treatment, and control. During the pandemic, a steeper increase in awareness, treatment, and control among participants being treated was observed. However, there were heterogeneous changes across different population groups, underscoring the need for targeted interventions to address disparities and improve diabetes management for susceptible populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Kyung Hee University College of Medicine, Seoul, Republic of Korea.
- Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, Republic of Korea.
- Department of Precision Medicine, Kyung Hee University College of Medicine, Seoul, Republic of Korea.
- Department of Regulatory Science, Kyung Hee University, Seoul, Republic of Korea.
- School of Medicine, Ulster University, Londonderry, United Kingdom.
- CEReSS-Health Service Research and Quality of Life Center, Aix-Marseille University, Marseille, France.
ORCID-Profile: Wonwoo Jang, Seokjun Kim, Yejun Son, Soeun Kim, Hyeon Jin Kim, Hyesu Jo, Jaeyu Park, Kyeongmin Lee, Hayeon Lee, Mark A Tully, Masoud Rahmati, Lee Smith, Jiseung Kang, Selin Woo, Sunyoung Kim, Jiyoung Hwang, Sang Youl Rhee, Dong Keon Yon
Zitieren
APA
Jang, W., Kim, S., Son, Y., Kim, S., Kim, H. J., Jo, H., Park, J., Lee, K., Lee, H., Tully, M. A., Rahmati, M., Smith, L., Kang, J., Woo, S., Kim, S., Hwang, J., Rhee, S. Y., & Yon, D. K. (2024). Prevalence, Awareness, Treatment, and Control of Type 2 Diabetes in South Korea (1998 to 2022): Nationwide Cross-Sectional Study. JMIR Public Health and Surveillance. https://doi.org/10.2196/59571
Vancouver
Jang W, Kim S, Son Y, Kim S, Kim HJ, Jo H, et al. Prevalence, Awareness, Treatment, and Control of Type 2 Diabetes in South Korea (1998 to 2022): Nationwide Cross-Sectional Study. JMIR Public Health and Surveillance. 2024. doi:10.2196/59571
BibTeX
@article{Jang2024,
author = {Jang, Wonwoo and Kim, Seokjun and Son, Yejun and Kim, Soeun and Kim, Hyeon Jin and Jo, Hyesu and Park, Jaeyu and Lee, Kyeongmin and Lee, Hayeon and Tully, Mark A and Rahmati, Masoud and Smith, Lee and Kang, Jiseung and Woo, Selin and Kim, Sunyoung and Hwang, Jiyoung and Rhee, Sang Youl and Yon, Dong Keon},
title = {Prevalence, Awareness, Treatment, and Control of Type 2 Diabetes in South Korea (1998 to 2022): Nationwide Cross-Sectional Study},
journal = {JMIR Public Health and Surveillance},
year = {2024},
doi = {10.2196/59571}
}
EUVIMED